Practices in Diagnosis of Benign Metastasizing Leiomyoma from the Retroperitoneum

1192Objectives: 1. Highlight the indications of PET imaging in BML. 2. Evaluate the characteristics of MRI in BML. 3. How to analyze and integrate the two imaging methods to make a correct diagnosis of BML. Abstract: Benign metastasizing leiomyoma (BML) is a rare disease entity that usually occurs in females of reproductive age with a prior history of uterine leiomyoma. Patients are usually asymptomatic and the tumors tend to grow gradually. 18FFDG PET/CT is useful for distinguishing malignant leiomyosarcoma from benign leiomyoma. The metabolic behavior of most BML cases in 18FFDG PET/CT is lacking/low uptake, and only a few cases have high FDG uptake. A 37-year-old female patient presented with a double adrenal mass upon routine physical examination. Ultrasonography suspected adrenal malignant metastases. To distinguish tumors from malignancy, the patient underwent PET/CT scans which showed low 18F-FDG uptake. More masses were detected in the left lower abdominal wall, uterus and pelvic cavity. The FDG activity in all the masses was unremarkable, which means those masses suggested to be benign. In this case, the relationship between the mass and the adrenal gland was determined by MRI. Dynamic contrast enhancement revealed a gradual contrast enhancement of masses, which is the characteristic appearance of leiomyoma enhancement on MRI. Retrace the patient history, the patient has a history of laparoscopic minimally invasive surgery for uterine fibroids when she was 35-year-ol...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Oncology Poster Session (Educational Exhbits) Source Type: research